Complement Factor H Polymorphism and Age-Related Macular Degeneration
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is a common, late-onset, and complex trait with multiple risk factors. Concentrating on a region harboring a locus for AMD on 1q25-31, the ARMD1 locus, we tested single-nucleotide polymorphisms for association with AMD in two independent case-control populations. Significant association ( P = 4.95 × 10 -10 ) was identified within the regulation of complement activation locus and was centered over a tyrosine-402 → histidine-402 protein polymorphism in the gene encoding complement factor H. Possession of at least one histidine at amino acid position 402 increased the risk of AMD 2.7-fold and may account for 50% of the attributable risk of AMD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A major AMD-associated SNP is the Y402H (tyrosine to histidine substitution at amino acid 402) variant of complement factor H (CFH) (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Edwards et al., 2005
In the citing paper
“These SNPs have been reported to be major genetic factors for developing AMD in Caucasians (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005; Tuo et al., 2006).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Edwards et al., 2005
In the citing paper
“Complement activation playing a major role in AMD pathogenesis is yet another source of inflammation [107-110].”
From Risk mitigation of immunogenicity: a key to personalized retinal gene therapy (2021) · cites this paper as [108]
In the citing paper
“Polymorphisms in human complement regulatory factor H (CFH) predispose individuals to AMD [35, 46, 59]”
From Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain (2022) · cites this paper as [35]
In the citing paper
“Genes in the complement pathway4–11 and a region of chromosome 10 12,13 have now been implicated as the major genetic contributors to disease.”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [4]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525
Prevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Score Tests for Association between Traits and Haplotypes when Linkage Phase Is Ambiguous
Schaid, D. J., Rowland, C. M., Tines, D. E., Jacobson, R. M., & Poland, G. A. (2002) · The American Journal of Human Genetics · doi:10.1086/338688 · Cited by 1,783
The Five-year Incidence and Progression of Age-related Maculopathy
Klein, R., Klein, B. E. K., Jensen, S. C., & Meuer, S. M. (1997) · Ophthalmology · doi:10.1016/s0161-6420(97)30368-6 · Cited by 1,135
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
The epidemiology of age-related macular degeneration
Klein, R., Peto, T., Bird, A., & Vannewkirk, M. R. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.069 · Cited by 932
Johnson, L. V., Leitner, W. P., Staples, M. K., & Anderson, D. H. (2001) · Experimental Eye Research · doi:10.1006/exer.2001.1094 · Cited by 621
Molecular Biology and Chemistry of the Alternative Pathway of Complement
Müller-Eberhard, H. J., & Schreiber, R. D. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60042-5 · Cited by 408
Seddon, J. M. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.6.785 · Cited by 398
Keenan, T. D., & Chew, E. Y. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.2210 · Cited by 377
Research works printed but not linked: 1
- M. H. Wener, P. R. Daum, G. M. McQuillan, J. Rheumatol.27, 2351 (2000).
Cited by
Items 101–200 of 1,021
Sennlaub, F., Auvynet, C., Calippe, B., Lavalette, S., Poupel, L., Hu, S. J., Dominguez, E., Camelo, S., Levy, O., Guyon, E., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302692 · Cited by 314
“Both forms of AMD are associated with a polymorphism of Complement factor H (CfH) (Edwards et al, 2005; Haines et al, 2005; Klein et al, 2005; Maller et al, 2006).”
A rare penetrant mutation in CFH confers high risk of age-related macular degeneration
Raychaudhuri, S., Iartchouk, O., Chin, K., Tan, P. L., Tai, A. K., Ripke, S., Gowrisankar, S., Vemuri, S., Montgomery, K., Yu, Y., et al. (2011) · Nature Genetics · doi:10.1038/ng.976 · Cited by 323
“Case patients had either geographic atrophy (advanced dry AMD) or neovascular disease (wet AMD) (Clinical Age-Related Maculopathy Grading System (CARMS) stages 4 and 5) 27 .”
Age‐related Macular Degeneration (AMD)
(2008) · Encyclopedia of Molecular Pharmacology · doi:10.1007/978-3-540-38918-7_5059 · Cited by 314
Cure therapeutics and strategic prevention: raising the bar for mental health research
Insel, T. R., & Scolnick, E. M. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001777 · Cited by 313
Chalasani, N., Guo, X., Loomba, R., Goodarzi, M. O., Haritunians, T., Kwon, S., Cui, J., Taylor, K. D., Wilson, L., Cummings, O. W., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.057 · Cited by 315
Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma
Zhang, K., Zhang, L., & Weinreb, R. N. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3745 · Cited by 316
Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates
Schneider, M. C., Prosser, B. E., Caesar, J. J. E., Kugelberg, E., Li, S., Zhang, Q., Quoraishi, S., Lovett, J. E., Deane, J. E., Sim, R. B., et al. (2009) · Nature · doi:10.1038/nature07769 · Cited by 314
Amyloid-β Deposits Lead to Retinal Degeneration in a Mouse Model of Alzheimer Disease
Ning, A., Cui, J., To, E., Ashe, K. H., & Matsubara, J. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-1849 · Cited by 303
Yehoshua, Z., Alexandre de Amorim Garcia Filho, C., Nunes, R. P., Gregori, G., Penha, F. M., Moshfeghi, A. A., Zhang, K., Sadda, S., Feuer, W., & Rosenfeld, P. J. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.09.044 · Cited by 299
The Genetics of Age-Related Macular Degeneration: A Review of Progress to Date
Haddad, S., Chen, C. A., Santangelo, S. L., & Seddon, J. M. (2006) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2006.05.001 · Cited by 299
Transplantation of the RPE in AMD
Binder, S., Stanzel, B. V., Krebs, I., & Glittenberg, C. (2007) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2007.02.002 · Cited by 292
De Córdoba, S. R., & De Jorge, E. G. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2007.03552.x · Cited by 287
Reynolds, R., Hartnett, M. E., Atkinson, J. P., Giclas, P. C., Rosner, B., & Seddon, J. M. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-3928 · Cited by 294
“of the amino acid serine for alanine at codon 69; (4) complement component 2 or C2BE318D (rs9332739), the nonsynonymous coding SNP variant in exon 7 of C2 resulting in a substitution of aspartic acid for glutamic acid at codon 318; (5) complement factor B or CFBR32Q (rs641153), the nonsynonymous coding SNP variant in…”
RPE necroptosis in response to oxidative stress and in AMD
Hanus, J., Anderson, C., & Wang, S. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.09.002 · Cited by 286
Dry Age-Related Macular Degeneration: Mechanisms, Therapeutic Targets, and Imaging
Bowes Rickman, C., Farsiu, S., Toth, C. A., & Klingeborn, M. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-12757 · Cited by 282
Pharmacogenomics: Challenges and Opportunities
Roden, D. M., Altman, R. B., Benowitz, N. L., Flockhart, D. A., Giacomini, K. M., Johnson, J. A., Krauss, R. M., McLeod, H. L., Ratain, M. J., Relling, M. V., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-10-200611210-00007 · Cited by 282
Spitzer, D., Mitchell, L. M., Atkinson, J. P., & Hourcade, D. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2600 · Cited by 280
Seddon, J. M., Reynolds, R., Maller, J., Fagerness, J. A., Daly, M. J., & Rosner, B. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-3064 · Cited by 285
“The following six common singlenucleotide polymorphisms (SNPs) associated with AMD were evaluated: (1) complement factor H (CFH) Y402H (rs1061170) in exon 9 of the CFH gene on chromosome 1, region q31, with the change 1277T C resulting in a substitution of a histidine for a tyrosine at codon 402 of the CFH protein; (2…”
Handa, J. T., Bowes Rickman, C., Dick, A. D., Gorin, M. B., Miller, J. W., Toth, C. A., Ueffing, M., Zarbin, M., & Farrer, L. A. (2019) · Nature Communications · doi:10.1038/s41467-019-11262-1 · Cited by 282
Self-citationApolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration
Malek, G., Johnson, L. V., Mace, B. E., Saloupis, P., Schmechel, D. E., Rickman, D. W., Toth, C. A., Sullivan, P. M., & Rickman, C. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503015102 · Cited by 284
Parallel findings in age-related macular degeneration and Alzheimer’s disease
Ohno-Matsui, K. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.02.004 · Cited by 280
“AMD was the first disease in which the GWAS approach identified the CFH gene as the responsible gene (Edwards et al., 2005; Haines et al., 2005; Klein et al., 2005).”
BackgroundChristenbury, J. G., Folgar, F. A., O'Connell, R. V., Chiu, S. J., Farsiu, S., & Toth, C. A. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.10.018 · Cited by 277
E2-2 Protein and Fuchs's Corneal Dystrophy
Baratz, K. H., Tosakulwong, N., Ryu, E., Brown, W. L., Branham, K., Chen, W., Tran, K. D., Schmid-Kubista, K. E., Heckenlively, J. R., Swaroop, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007064 · Cited by 279
Self-citationImpaired Cholesterol Efflux in Senescent Macrophages Promotes Age-Related Macular Degeneration
Sene, A., Khan, A. A., Cox, D., Nakamura, R. E. I., Santeford, A., Kim, B. M., Sidhu, R., Onken, M. D., Harbour, J. W., Hagbi-Levi, S., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.009 · Cited by 277
“…to alternative proangiogenic polarization of these cells, which in the appropriate genetic context of polymorphisms in complement regulatory genes (Edwards et al., 2005), and alongside environmental cues such as smoking, can create a lethal micromilieu for the development and progression of…”
InfluentialNewman, A. M., Gallo, N. B., Hancox, L. S., Miller, N. J., Radeke, C. M., Maloney, M. A., Cooper, J. B., Hageman, G. S., Anderson, D. H., Johnson, L. V., et al. (2012) · Genome Medicine · doi:10.1186/gm315 · Cited by 270
“Through an extensive PubMed search and survey of recent review articles, we assembled a large list of genes or gene products with a confirmed or putative association with AMD resulting from genetic linkage, expression differences (RNA or protein) or localization to drusen in humans [15-33,40,54-110].”
BackgroundMethodBoyer, D. S., Schmidt-Erfurth, U., van Lookeren Campagne, M., Henry, E. C., & Brittain, C. (2017) · Retina · doi:10.1097/iae.0000000000001392 · Cited by 258
Swaroop, A., Chew, E. Y., Bowes Rickman, C., & Abecasis, G. R. (2009) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.9.081307.164350 · Cited by 270
“Initial reports of association included candidate gene approach, fine mapping of candidate loci, and the first successful whole-genome association study in humans (40, 63, 65, 95) and were immediately replicated (175).”
Combining Information from Common Type 2 Diabetes Risk Polymorphisms Improves Disease Prediction
Weedon, M. N., McCarthy, M. I., Hitman, G., Walker, M., Groves, C. J., Zeggini, E., Rayner, N. W., Shields, B., Owen, K. R., Hattersley, A. T., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030374 · Cited by 268
Burton, P. R., Hansell, A. L., Fortier, I., Manolio, T. A., Khoury, M. J., Little, J., & Elliott, P. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyn147 · Cited by 258
The complement system in age-related macular degeneration
Armento, A., Ueffing, M., & Clark, S. J. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03796-9 · Cited by 258
Marc, R. E., Jones, B. W., Watt, C. B., Vázquez-Chona, F., Vaughan, D. K., & Organisciak, D. T. (2008) · PubMed Central · Cited by 283
Yu, Y., Bhangale, T. R., Fagerness, J., Ripke, S., Thorleifsson, G., Tan, P. L., Souied, E. H., Richardson, A. J., Merriam, J. E., Buitendijk, G. H. S., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr270 · Cited by 254
Miller, J. W. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.10.018 · Cited by 250
“As discussed previously, the aging Bruch membrane displays increased levels of TIMPs, a situation that is associated with reduced ECM turnover and thickening of the Bruch membrane.(22,23)”
BackgroundPentraxins: Structure, Function, and Role in Inflammation
Du Clos, T. W. (2013) · ISRN Inflammation · doi:10.1155/2013/379040 · Cited by 248
Aging is not a disease: Distinguishing age-related macular degeneration from aging
Ardeljan, D., & Chan, C.-C. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.07.003 · Cited by 242
“Genetic association studies have linked complement factor H (CFH) (Edwards et al., 2005; Haines et al., 2005; Klein et al., 2005), C2/complement factor B (CFB) (Gold et al., 2006; Spencer et al., 2007), CFHR1/CFHR3 (Fritsche et al., 2010; Hughes et al., 2006), C3 (Yates et al., 2007), and C5 (Baas…”
BackgroundInfluentialJakobsdottir, J., Gorin, M. B., Conley, Y. P., Ferrell, R. E., & Weeks, D. E. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000337 · Cited by 245
Macrophages inhibit neovascularization in a murine model of age-related macular degeneration
Apte, R. S., Richter, J., Herndon, J., & Ferguson, T. A. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030310 · Cited by 249
“Recent genetic-linkage-based evidence suggests the potential importance of complement factor H in AMD [9,11,12].”
BackgroundBian, Q., Gao, S., Zhou, J., Qin, J., Taylor, A., Johnson, E. J., Tang, G., Sparrow, J. R., Gierhart, D., & Shang, F. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.06.024 · Cited by 241
Age-related macular degeneration (AMD): Alzheimer's disease in the eye?
Kaarniranta, K., Salminen, A., Haapasalo, A., Soininen, H., & Hiltunen, M. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101908 · Cited by 248
Genome-Wide Association Studies in Alzheimer Disease
Waring, S. C., & Rosenberg, R. N. (2008) · Archives of Neurology · doi:10.1001/archneur.65.3.329 · Cited by 236
Hageman, G. S., Hancox, L. S., Taiber, A. J., Gehrs, K. M., Anderson, D. H., Johnson, L. V., Radeke, M. J., Kavanagh, D., Richards, A., Atkinson, J., et al. (2006) · Annals of Medicine · doi:10.1080/07853890601097030 · Cited by 246
Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein
Laine, M., Jarva, H., Seitsonen, S., Haapasalo, K., Lehtinen, M. J., Lindeman, N., Anderson, D. H., Johnson, P. T., Järvelä, I., Jokiranta, T. S., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3831 · Cited by 246
Meta-analysis of genome scans of age-related macular degeneration
Fisher, S. A., Abecasis, G. R., Yashar, B. M., Zareparsi, S., Swaroop, A., Iyengar, S. K., Klein, B. E. K., Klein, R., Lee, K. E., Majewski, J., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi230 · Cited by 239
The Role of Properdin in the Assembly of the Alternative Pathway C3 Convertases of Complement
Hourcade, D. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508928200 · Cited by 232
Age and disease-related structural changes in the retinal pigment epithelium
Bonilha, V. (2008) · Clinical Ophthalmology · doi:10.2147/opth.s2151 · Cited by 226
“…by the Y402H polymorphism in the complement factor H gene on 1q, is a recognized risk factor for AMD, as is the A69S variant in the poorly characterized LOC387715 gene and the serine protease HTRA1 in multiple populations (Edwards et Age-and disease-related changes in the RPE Yang et al 2006).”
Heurich, M., Martínez-Barricarte, R., Francis, N. J., Roberts, D. L., Rodríguez de Córdoba, S., Morgan, B. P., & Harris, C. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019338108 · Cited by 231
The Membrane Attack Complex in Aging Human Choriocapillaris
Mullins, R. F., Schoo, D. P., Sohn, E. H., Flamme-Wiese, M. J., Workamelahu, G., Johnston, R. M., Wang, K., Tucker, B. A., & Stone, E. M. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.07.017 · Cited by 228
SOD2 knockdown mouse model of early AMD
Justilien, V., Pang, J.-J., Renganathan, K., Zhan, X., Crabb, J. W., Kim, S. R., Sparrow, J. R., Hauswirth, W. W., & Lewin, A. S. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0432 · Cited by 234
Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better?
Burgner, D., Jamieson, S. E., & Blackwell, J. M. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70601-6 · Cited by 226
Macular degeneration: recent advances and therapeutic opportunities
Rattner, A., & Nathans, J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn2007 · Cited by 231
Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction
Coffey, P. J., Gias, C., McDermott, C. J., Lundh, P., Pickering, M. C., Sethi, C., Bird, A., Fitzke, F. W., Maass, A., Chen, L. L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705079104 · Cited by 231
Khan, K. N., Mahroo, O. A., Khan, R. S., Mohamed, M. D., McKibbin, M., Bird, A., Michaelides, M., Tufail, A., & Moore, A. T. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.04.008 · Cited by 224
“This variant (Y402H) is associated with functional consequences, as it limits the binding of CFH to various complement-activating targets, reducing its inhibitory activity and thus prolonging the activity of C3 convertase (Herbert et al., 2007; Laine et al., 2007).”
BackgroundInfluentialCigarette Smoking and Age-Related Macular Degeneration in the EUREYE Study
Chakravarthy, U., Augood, C., Bentham, G. C., de Jong, P. T. V. M., Rahu, M., Seland, J., Soubrane, G., Tomazzoli, L., Topouzis, F., Vingerling, J. R., et al. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.09.022 · Cited by 230
MicroRNA‐204/211 alters epithelial physiology
Wang, F. E., Zhang, C., Maminishkis, A., Dong, L., Zhi, C., Li, R., Zhao, J., Majerciak, V., Gaur, A. B., Chen, S., et al. (2010) · The FASEB Journal · doi:10.1096/fj.08-125856 · Cited by 230
Complex Trait Genetics of Refractive Error
Young, T. L. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.1.38 · Cited by 223
Thakkinstian, A., Han, P., McEvoy, M., Smith, W., Hoh, J., Magnusson, K., Zhang, K., & Attia, J. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl220 · Cited by 223
CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD
Magnusson, K. P., Duan, S., Sigurdsson, H., Petursson, H., Yang, Z., Zhao, Y., Bernstein, P. S., Ge, J., Jonasson, F., Stefansson, E., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0030005 · Cited by 226
The Aging Eye: Common Degenerative Mechanisms Between the Alzheimer's Brain and Retinal Disease
Sivak, J. M. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-10827 · Cited by 220
Genetic Etiologies of Glaucoma
Wiggs, J. L. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.1.30 · Cited by 225
Johnson, P. T., Betts, K. E., Radeke, M. J., Hageman, G. S., Anderson, D. H., & Johnson, L. V. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606234103 · Cited by 223
Whitmore, S. S., Sohn, E. H., Chirco, K. R., Drack, A. V., Stone, E. M., Tucker, B. A., & Mullins, R. F. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.11.005 · Cited by 218
“These two features made the detection of the risk allele possible in even a relatively small series of cases and controls (Edwards et al., 2005), whereas SNPs with smaller effect size and lower frequency require thousands of cases and controls (e.”
BackgroundOxidative Stress and the Regulation of Complement Activation in Human Glaucoma
Tezel, G., Yang, X., Luo, C., Kain, A. D., Powell, D. W., Kuehn, M. H., & Kaplan, H. J. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5289 · Cited by 222
Toll-like Receptor 3 and Geographic Atrophy in Age-Related Macular Degeneration
Yang, Z., Stratton, C., Francis, P. J., Kleinman, M. E., Tan, P. L., Gibbs, D., Tong, Z., Chen, H., Constantine, R., Yang, X., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802437 · Cited by 222
Neovascular Age-Related Macular Degeneration: Therapeutic Management and New-Upcoming Approaches
Ricci, F., Bandello, F., Navarra, P., Staurenghi, G., Stumpp, M., & Zarbin, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218242 · Cited by 208
Chirco, K. R., Sohn, E. H., Stone, E. M., Tucker, B. A., & Mullins, R. F. (2017) · Eye · doi:10.1038/eye.2016.216 · Cited by 215
Complement and diseases: Defective alternative pathway control results in kidney and eye diseases
Zipfel, P. F., Heinen, S., Józsi, M., & Skerka, C. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.06.015 · Cited by 218
Nguyen, D. D., Luo, L.-J., Yang, C.-J., & Lai, J.-Y. (2023) · ACS Nano · doi:10.1021/acsnano.2c05824 · Cited by 213
Abrera-Abeleda, M. A., Nishimura, C., Smith, J. L. H., Sethi, S., McRae, J. L., Murphy, B. F., Silvestri, G., Skerka, C., Józsi, M., Zipfel, P. F., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.038315 · Cited by 216
A New Map of Glycosaminoglycan and C3b Binding Sites on Factor H
Schmidt, C. Q., Herbert, A. P., Kavanagh, D., Gandy, C., Fenton, C. J., Blaum, B. S., Lyon, M., Uhrín, D., & Barlow, P. N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2610 · Cited by 208
Marazita, M. C., Dugour, A., Marquioni-Ramella, M. D., Figueroa, J. M., & Suburo, A. M. (2016) · Redox Biology · doi:10.1016/j.redox.2015.11.011 · Cited by 207
Stem cell based therapies for age-related macular degeneration: The promises and the challenges
Nazari, H., Zhang, L., Zhu, D., Chader, G. J., Falabella, P., Stefanini, F., Rowland, T., Clegg, D. O., Kashani, A. H., Hinton, D. R., et al. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.06.004 · Cited by 206
Wang, R., Li, Y. F., Wang, X., Tang, H., & Zhou, X. (2009) · Proceedings of the 16th ACM conference on Computer and communications security · doi:10.1145/1653662.1653726 · Cited by 211
“GWAS, with its’ first papers came out in 2005 [33, 39], is a new population genetics approach that was enabled by the high throughput genome technology and advanced computational methods [51].”
Geerlings, M. J., de Jong, E. K., & den Hollander, A. I. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2016.11.016 · Cited by 201
Efficient Non-Viral Ocular Gene Transfer with Compacted DNA Nanoparticles
Farjo, R., Skaggs, J., Quiambao, A. B., Cooper, M. J., & Naash, M. I. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000038 · Cited by 208
Compstatin: a C3‐targeted complement inhibitor reaching its prime for bedside intervention
Mastellos, D. C., Yancopoulou, D., Kokkinos, P., Huber‐Lang, M., Hajishengallis, G., Biglarnia, A. R., Lupu, F., Nilsson, B., Risitano, A. M., Ricklin, D., et al. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12419 · Cited by 206
Primary open-angle glaucoma genes
Fingert, J. H. (2011) · Eye · doi:10.1038/eye.2011.97 · Cited by 209
Recent developments in the treatment of age-related macular degeneration
Holz, F. G., Schmitz-Valckenberg, S., & Fleckenstein, M. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71029 · Cited by 206
“The role of the alternative complement pathway in AMD pathogenesis has been underscored by the discovery of an association between CFH (28–31) and other risk-conferring polymorphisms in this pathway, including CFB , C2 , C3 , and CFI (32–36).”
Grant, S. F. A., Li, M., Bradfield, J. P., Kim, C. E., Annaiah, K., Santa, E., Glessner, J. T., Casalunovo, T., Frackelton, E. C., Otieno, F. G., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001746 · Cited by 202
“Recently, a number of studies have reported remarkably strong, replicable associations with complex disease, including the complement factor H (CFH) gene in age-related macular degeneration[24,25,26] and the transcription factor 7-like-2 (TCF7L2) gene in type 2 diabetes[27,28,29].”
BackgroundAnatomy and development of the macula: specialisation and the vulnerability to macular degeneration
Provis, J. M., Penfold, P. L., Cornish, E. E., Sandercoe, T. M., & Madigan, M. C. (2005) · Clinical and Experimental Optometry · doi:10.1111/j.1444-0938.2005.tb06711.x · Cited by 195
Protection of host cells by complement regulators
Schmidt, C. Q., Lambris, J. D., & Ricklin, D. (2016) · Immunological Reviews · doi:10.1111/imr.12475 · Cited by 211
Tuo, J., Bojanowski, C. M., Zhou, M., Shen, D., Ross, R. J., Rosenberg, K. I., Cameron, D. J., Yin, C., Kowalak, J. A., Zhuang, Z., et al. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0051 · Cited by 205
Ho, L. (2011) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.141 · Cited by 199
Fritsche, L. G., Lauer, N., Hartmann, A., Stippa, S., Keilhauer, C. N., Oppermann, M., Pandey, M. K., Köhl, J., Zipfel, P. F., Weber, B. H. F., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq399 · Cited by 203
“Several studies have identified the complement factor H (CFH) gene on chromosome 1q31 as a major AMD susceptibility gene (2-5).”
BackgroundLuibl, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25843 · Cited by 203
The complex nature of serum C3 and C4 as biomarkers of lupus renal flare
Birmingham, D., Irshaid, F., Nagaraja, H., Zou, X., Tsao, B., Wu, H., Yu, C., Hebert, L., & Rovin, B. (2010) · Lupus · doi:10.1177/0961203310371154 · Cited by 201
A High-Resolution Map of Segmental DNA Copy Number Variation in the Mouse Genome
Graubert, T. A., Cahan, P., Edwin, D., Selzer, R. R., Richmond, T. A., Eis, P. S., Shannon, W. D., Li, X., McLeod, H. L., Cheverud, J. M., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030003 · Cited by 203
The potential role of amyloid in the pathogenesis of age-related macular degeneration
Yoshida, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24635 · Cited by 202
Recent Developments in Genomewide Association Scans: A Workshop Summary and Review
Thomas, D. C., Haile, R. W., & Duggan, D. (2005) · The American Journal of Human Genetics · doi:10.1086/432962 · Cited by 203
Brantley, M. A., Fang, A. M., King, J. M., Tewari, A., Kymes, S. M., & Shiels, A. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.09.008 · Cited by 201
Kinnunen, K., Petrovski, G., Moe, M. C., Berta, A., & Kaarniranta, K. (2012) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2011.02179.x · Cited by 197
“…ligands induces the expression and secretion of pro-inflammatory cytokines (e.g. IL-6, IL-8), angiogenetic chemokines (e.g. CXCL8, CCL2) and adhesion markers (e.g. ICAM-1, VCAM-1) (Elner et al. 2003, 2005; Kindzelskii et al. 2004; Kumar et al. 2004; Ebihara et al. 2007; Paimela et al. 2007).”
BackgroundS. Reis, E., Falcão, D. A., & Isaac, L. (2006) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2006.01729.x · Cited by 192
Moving toward a system genetics view of disease
Sieberts, S. K., & Schadt, E. E. (2007) · Mammalian Genome · doi:10.1007/s00335-007-9040-6 · Cited by 194
“eases like age-related macular degeneration (Edwards et al. 2005; Haines 2005; Klein 2005), diabetes (Grant 2006;”
BackgroundSeddon, J. M., Reynolds, R., Yu, Y., Daly, M. J., & Rosner, B. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.04.029 · Cited by 198
Genetic association analysis of copy-number variation (CNV) in human disease pathogenesis
Ionita-Laza, I., Rogers, A. J., Lange, C., Raby, B. A., & Lee, C. (2009) · Genomics · doi:10.1016/j.ygeno.2008.08.012 · Cited by 198
Atypical Haemolytic Uraemic Syndrome Associated with a Hybrid Complement Gene
Venables, J. P., Strain, L., Routledge, D., Bourn, D., Powell, H. M., Warwicker, P., Diaz-Torres, M. L., Sampson, A., Mead, P., Webb, M., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030431 · Cited by 195
Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration
Skerka, C., Lauer, N., Weinberger, A. A. W. A., Keilhauer, C. N., Sühnel, J., Smith, R., Schlötzer–Schrehardt, U., Fritsche, L., Heinen, S., & Hartmann, A. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.02.012 · Cited by 197
Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma
Steele, M. R., Inman, D. M., Calkins, D. J., Horner, P. J., & Vetter, M. L. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0865 · Cited by 196
AUGUSTIN, A. J., PULS, S., & OFFERMANN, I. (2007) · Retina · doi:10.1097/iae.0b013e3180323de7 · Cited by 193
Phospholipid meets all-trans-retinal: the making of RPE bisretinoids
Sparrow, J. R., Wu, Y., Kim, C. Y., & Zhou, J. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r000687 · Cited by 193
Spencer, K. L., Hauser, M. A., Olson, L. M., Schmidt, S., Scott, W. K., Gallins, P., Agarwal, A., Postel, E. A., Pericak-Vance, M. A., & Haines, J. L. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm146 · Cited by 190
“The purpose of these analyses is 2-fold: (1) to estimate the effect sizes of CC2 E318D and CFB R32Q in the context of accepted AMD risk factors and (2) to provide a framework for likelihood ratio tests of model fit when CC2 E318D and CFB R32Q are included in the models (see Table 7).”
Method
Metadata
- Authors
- Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A.
- Affiliations
- Boston University (US)
- Corresponding author
- Edwards, Albert O.
- Venue
- Science
- Published
- 2005-04-15
- Volume
- 308
- Issue
- 5720
- Pages
- 421-424
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W3145351529
- Cited by
- 2,449
- References
- 30
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 51 · 2023: 48 · 2022: 78 · 2021: 105 · 2020: 73 · 2019: 52 · 2018: 81 · 2017: 65 · 2016: 89 · 2015: 120 · 2014: 141 · 2013: 146 · 2012: 166
- FWCI
- 195.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (EY014467, R01EY014467)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- age-related macular degeneration, complement factor H, CFH Y402H polymorphism, single nucleotide polymorphisms, genetic association, disease risk
- MeSH terms
- Aged, Alleles, Chromosomes, Human, Pair 1, Complement Activation, Female, Gene Frequency, Multigene Family, Genotype, Haplotypes, Histidine, Homozygote, Humans, Macular Degeneration, Male, Middle Aged, Risk Factors, Tyrosine, Genetic Variation, Linkage Disequilibrium, Case-Control Studies, Complement Factor H, Amino Acid Substitution, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.